安諾倫(北京)生物科技有限公司是一家創(chuàng)辦于2015年的創(chuàng)新型高科技企業(yè),公司由在國內(nèi)科研試劑領(lǐng)域有著十幾年從業(yè)經(jīng)驗(yàn)的專業(yè)技術(shù)團(tuán)隊(duì)和企業(yè)管理團(tuán)隊(duì)組建而成,專門從事以抗體、蛋白、細(xì)胞、化學(xué)品為核心的試劑產(chǎn)品研發(fā)與銷售。擁有國內(nèi)外數(shù)百家品牌試劑代理權(quán),為眾多需求客戶及科研機(jī)構(gòu)提供品質(zhì)保障、價格合理和操作便捷的品牌試劑。
PNA生物提供優(yōu)質(zhì)的PNA(肽核酸)產(chǎn)品,包括定制的寡糖,F(xiàn)ISH探針,miRNA抑制劑,PNA鉗夾探針和FMOC單體。
PNA BIO INC is devoted to provide quality research products and services to the laboratories of basic research and applied field.
PNA Bio offer quality PNA (Peptide Nucleic Acid) products including custom oligos, FISH probes, miRNA inhibitors, PNA clamp probes and Fmoc monomers. They are provided >95% purity after HPLC purification along with MS/MS data. PNA products are manufactured by Panagene.
PNA Bio also provides engineered nuclease service including CRISPR/Cas9 nucleases (RGEN) synthesis, validation and Cas9 protein in addition to knock-out and knock-in cell line services. RGEN and related products are manufactured by ToolGen Inc.
品牌 | 貨號 | 名稱 | 規(guī)格 |
Pnabio | F1001 | TelC telomere probe | 1 |
Pnabio | CP01 | Cas9 protein with NLS (injection ready);reconstitutes to 1 mg/ml (6 uM) | 250 ug (1530 pmol / 30 uM x 50 ul) |
Pnabio | CP02 | Cas9 protein with NLS (injection ready); reconstitutes to 5 mg/ml (30 uM); | 1 mg (250 ug x 4) |
Pnabio | CP03 | Cas9 protein with NLS (injection ready); reconstitutes to 5 mg/ml (30 uM); | 100 ug (20 ug x 5) |
Pnabio | CP04-100 | Cas9 protein with NLS (injection ready); Liquid form, 1 mg/ml (6 uM); | 500 ug (100 ug x 5) |
Pnabio | CP04-500 | Cas9 protein with NLS (injection ready); Liquid form, 5 mg/ml (30 uM); | 50 ug |
相關(guān)產(chǎn)品
免責(zé)聲明
- 凡本網(wǎng)注明“來源:化工儀器網(wǎng)”的所有作品,均為浙江興旺寶明通網(wǎng)絡(luò)有限公司-化工儀器網(wǎng)合法擁有版權(quán)或有權(quán)使用的作品,未經(jīng)本網(wǎng)授權(quán)不得轉(zhuǎn)載、摘編或利用其它方式使用上述作品。已經(jīng)本網(wǎng)授權(quán)使用作品的,應(yīng)在授權(quán)范圍內(nèi)使用,并注明“來源:化工儀器網(wǎng)”。違反上述聲明者,本網(wǎng)將追究其相關(guān)法律責(zé)任。
- 本網(wǎng)轉(zhuǎn)載并注明自其他來源(非化工儀器網(wǎng))的作品,目的在于傳遞更多信息,并不代表本網(wǎng)贊同其觀點(diǎn)和對其真實(shí)性負(fù)責(zé),不承擔(dān)此類作品侵權(quán)行為的直接責(zé)任及連帶責(zé)任。其他媒體、網(wǎng)站或個人從本網(wǎng)轉(zhuǎn)載時,必須保留本網(wǎng)注明的作品第一來源,并自負(fù)版權(quán)等法律責(zé)任。
- 如涉及作品內(nèi)容、版權(quán)等問題,請?jiān)谧髌钒l(fā)表之日起一周內(nèi)與本網(wǎng)聯(lián)系,否則視為放棄相關(guān)權(quán)利。